. 2018 Aug 10;9(62):31985–31998. doi: 10.18632/oncotarget.25868

Table 2. Concentration of metabolites about glycolysis in USC cells.

Compound name	Concentration (pmol/10⁶ cells)
Compound name	USPC-1(Control)		USPC-1(Paclitaxel)		PTX-1(Control)		PTX-1(Paclitaxel)		USPC-1(Paclitaxel) vs USPC-1(Control)		PTX-1(Paclitaxel) vs PTX-1(Control)		PTX-1(Control) vs USPC-1(Control)		PTX-1(Paclitaxel) vs USPC-1(Paclitaxel)
	Mean	S.D.	Mean	S.D.	Mean	S.D.	Mean	S.D.	Ratio	P value	Ratio	P value	Ratio	P value	Ratio	P value
NAD+	3,308	1,684	5,126	463	4,368	509	4,322	81	1.5	0.197	1.0	0.890	1.3	0.392	0.8	0.091
NADH	162	15	241	19	169	14	184	N.A.	1.5	0.006^*	1.1	N.A.	1.0	0.598	0.8	N.A.
UDP-glucose	235	39	244	21	446	58	420	38	1.0	0.756	0.9	0.560	1.9	0.009^*	1.7	0.005^*
G6P	56	20	58	12	126	13	94	5.8	1.0	0.898	0.7	0.037^*	2.3	0.001^*	1.6	0.019^*
F1, 6P	24	6.4	40	6.9	70	11	70	14	1.7	0.036^*	1.0	0.980	3.0	0.006^*	1.7	0.050
ADP	716	159	1,319	98	1,118	125	1,364	89	1.8	0.009^*	1.2	0.056	1.6	0.029^*	1.0	0.588
GTP	1,815	707	2,550	90	2,059	280	1,998	28	1.4	0.212	1.0	0.740	1.1	0.622	0.8	0.005^*
ATP	11,072	5,718	15,846	651	10,294	1,417	9,452	631	1.4	0.284	0.9	0.422	0.9	0.838	0.6	2.6E-04^*
NADPH/NADP+	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.
NADH/NAD+	0.06	0.04	0.05	0.008^*	0.04	0.005	0.04	N.A.	0.8	0.591	1.1	N.A.	0.6	0.426	0.9	N.A.
G6P/R5P	17	N.A.	89	N.A	15	2.9	29	15	5.1	N.A.	2.0	0.236	0.9	N.A.	0.3	N.A.

NAD; nicotinamide adenine dinucleotide, NADH; reduced nicotinamide adenine dinucleotide, G6P; glucose 6-phosphate, F1, 6P; fluctose 1,6-diphosphate, R5P; ribose 5-phosphate, NADPH; reduced nicotinamide adenine dinucleotide phosphate, NADP; nicotinamide adenine dinucleotide phosphate, S.D.; standard deviation, ^*P < 0.05, N.A.; not available.